12/02/2024
8:02 PM | ADMA Biologics (Issuer)
ELMS STEVE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
8:00 PM | ADMA Biologics (Subject)
Tade Brad L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2024
8:00 PM | ADMA Biologics (Subject)
Grossman Adam S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2024
8:05 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
8:05 PM | ADMA Biologics (Issuer)
Tade Brad L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
3:30 PM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
12:34 PM | ADMA Biologics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
|
11/08/2024
8:21 AM | ADMA Biologics (Subject)
Invesco Ltd. (Filed by)
| Form SC 13G | |
11/07/2024
4:00 PM | ADMA Biologics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
10:00 AM | ADMA Biologics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G | |
10/31/2024
4:25 PM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
8:22 AM | ADMA Biologics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G | |
10/10/2024
8:29 AM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
4:25 PM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
8:00 PM | ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/23/2024
3:27 PM | ADMA Biologics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G | |
09/11/2024
8:00 PM | ADMA Biologics (Issuer)
Guiheen Lawrence P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
8:00 PM | ADMA Biologics (Subject)
Guiheen Lawrence P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024
8:00 PM | ADMA Biologics (Subject)
Kestenberg-Messina Kaitlin M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024
8:02 PM | ADMA Biologics (Issuer)
Grossman Jerrold B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
8:05 PM | ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
8:26 PM | ADMA Biologics (Subject)
Grossman Jerrold B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/27/2024
8:22 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
8:00 PM | ADMA Biologics (Issuer)
KWON YOUNG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
8:28 PM | ADMA Biologics (Subject)
Grossman Adam S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2024
8:05 AM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
4:00 PM | ADMA Biologics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/26/2024
8:00 PM | ADMA Biologics (Issuer)
Tade Brad L. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/26/2024
8:05 PM | ADMA Biologics (Issuer)
Tade Brad L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/26/2024
8:10 PM | ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/26/2024
4:15 PM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2024
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
8:01 PM | ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
3:34 PM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:15 PM | ADMA Biologics (Subject)
Grossman Adam S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2024
8:00 AM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
4:01 PM | ADMA Biologics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
3:06 PM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2024
3:35 PM | ADMA Biologics (Filer)
| Form DEFA14A | |
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad) All of our key indicators are flashing the same signal: an altcoin season is fast approaching.
And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin |
04/15/2024
3:40 PM | ADMA Biologics (Filer)
| Form ARS | |
04/15/2024
3:31 PM | ADMA Biologics (Filer)
| Form DEF 14A | |
04/02/2024
8:00 PM | ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/02/2024
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
8:01 PM | ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
8:48 PM | ADMA Biologics (Issuer)
ELMS STEVE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
8:00 PM | ADMA Biologics (Issuer)
ELMS STEVE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:44 PM | ADMA Biologics (Subject)
Aisling Capital II LP (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
11:31 AM | ADMA Biologics (Subject)
TEACHERS ADVISORS, LLC (Filed by)
| Form SC 13G/A | |
03/11/2024
11:24 AM | ADMA Biologics (Subject)
TIAA CREF INVESTMENT MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
03/11/2024
11:19 AM | ADMA Biologics (Subject)
Nuveen Asset Management, LLC (Filed by)
| Form SC 13G/A | |
03/08/2024
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
8:01 PM | ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
8:00 PM | ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
8:00 PM | ADMA Biologics (Issuer)
ELMS STEVE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
8:00 PM | ADMA Biologics (Issuer)
Fong Bryant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
8:00 PM | ADMA Biologics (Issuer)
Guiheen Lawrence P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
8:00 PM | ADMA Biologics (Issuer)
KWON YOUNG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
8:00 PM | ADMA Biologics (Issuer)
Grossman Jerrold B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
8:00 PM | ADMA Biologics (Issuer)
FINGER ALISON CECILY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
3:15 PM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
3:21 PM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
8:03 PM | ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
7:00 AM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
10:47 AM | ADMA Biologics (Subject)
TEACHERS ADVISORS, LLC (Filed by)
| Form SC 13G | |
02/14/2024
10:50 AM | ADMA Biologics (Subject)
Nuveen Asset Management, LLC (Filed by)
| Form SC 13G | |
02/14/2024
10:37 AM | ADMA Biologics (Subject)
TIAA CREF INVESTMENT MANAGEMENT LLC (Filed by)
| Form SC 13G | |
01/08/2024
7:00 AM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
6:30 AM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
8:00 PM | ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:30 PM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
